Study Compares Safety of JAK Inhibitors Between Adolescent, Adult Patients - HCPLive
Pediatric JAKi patients report more lymphatic and blood disorders, while adults report more nervous and musculoskeletal system disorders. Research by Talasila et al. analyzed FDA databases (2011-2023) for 5 approved JAK inhibitors in pediatric patients, finding common AEs in both age groups but with notable differences in distribution.
Reference News
Study Compares Safety of JAK Inhibitors Between Adolescent, Adult Patients - HCPLive
Pediatric JAKi patients report more lymphatic and blood disorders, while adults report more nervous and musculoskeletal system disorders. Research by Talasila et al. analyzed FDA databases (2011-2023) for 5 approved JAK inhibitors in pediatric patients, finding common AEs in both age groups but with notable differences in distribution.